Innate Pharma S.a. sell Lokrim
Start price
22.01.24
/
20%
€2.40
Target price
22.01.25
-
Performance (%)
-20.00%
End price
17.08.24
€1.92
Summary
This prediction ended on 17.08.24 with a price of €1.92. The price of Innate Pharma S.a. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -20.00%. Lokrim has a follow-up prediction for Innate Pharma S.a. where he still thinks Innate Pharma S.a. is a Sell. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innate Pharma S.a. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to Lokrim what are the pros and cons of Innate Pharma S.a. for the foreseeable future?
Pros
Cons
Business model of the past or high risk
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Innate Pharma S.a. diskutieren
Sell Innate Pharma S.a.
In the thread Trading Innate Pharma S.a.
Current prediction by Lokrim for Innate Pharma S.a.
Innate Pharma S.a.
Start price
Target price
Perf. (%)
€2.22
15.12.24
15.12.24
-
15.12.25
15.12.25
-27.03%
11.12.25
11.12.25
Business model of the past or high risk
Probably not worthwhile Investment
